Shanghai Yizhong Pharmaceutical Co. Ltd.SSE: 688091

Shareholder's Inquiry Transfer Plan

Jul 17, 2025 · Issued by Shanghai Yizhong Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 17, 2025

On 6ix: 6ix.com/news/shareholders-inquiry-transfer-plan-14

Shareholder's Inquiry Transfer Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Yizhong Pharmaceutical Co. Ltd. on 6ix

Earlier from Shanghai Yizhong Pharmaceutical

Announcement on Change of Sponsor Representative for Continuous SupervisionJun 10, 2025
Announcement on "Corporate Value and Return Enhancement" Action Plan 2025Jun 7, 2025
Announcement on Resolutions of the 2024 Annual General MeetingMay 30, 2025
Announcement on Plan of Shareholding Reduction by Shareholders through Call AuctionMay 21, 2025
Notice on Convening the 2024 Annual General MeetingMay 9, 2025

Later from Shanghai Yizhong Pharmaceutical

Indicative Announcement on Pricing for Shareholder Inquiry TransferJul 18, 2025
Report on the Transfer Result of Shareholders' Inquiry and Indicative Announcement on Change in Equity of Shareholder with Reaching 5% Shares Exceeding Integer Multiple of 1%Jul 23, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025Aug 8, 2025
Announcement on Convening the Semi-annual Collective Performance Briefing for Innovative Drug Industry on SSE STAR Market 2025Sep 9, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025Sep 13, 2025

All Shanghai Yizhong Pharmaceutical news releases

Follow Shanghai Yizhong Pharmaceutical into a list and get an email when it puts out news.

Follow Shanghai Yizhong Pharmaceutical